Cargando…
Cancer cost profiles: The Epicost estimation approach
Sustainability of cancer burden is becoming increasingly central in the policy makers' debate, and poses a challenge for the welfare systems, due to trends towards greater intensity of healthcare service use, which imply increasing costs of cancer care. Measuring and projecting the economic bur...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533128/ https://www.ncbi.nlm.nih.gov/pubmed/36211660 http://dx.doi.org/10.3389/fpubh.2022.974505 |
_version_ | 1784802277034295296 |
---|---|
author | Francisci, Silvia Capodaglio, Guilia Gigli, Anna Mollica, Cristina Guzzinati, Stefano |
author_facet | Francisci, Silvia Capodaglio, Guilia Gigli, Anna Mollica, Cristina Guzzinati, Stefano |
author_sort | Francisci, Silvia |
collection | PubMed |
description | Sustainability of cancer burden is becoming increasingly central in the policy makers' debate, and poses a challenge for the welfare systems, due to trends towards greater intensity of healthcare service use, which imply increasing costs of cancer care. Measuring and projecting the economic burden associated with cancer and identifying effective policies for minimising its impact are important issues for healthcare systems. Scope of this paper is to illustrate a novel comprehensive approach (called Epicost) to the estimation of the economic burden of cancer, based on micro-data collected from multiple data sources. It consists of a model of cost analysis to estimate the amount of reimbursement payed by the National Health Service to health service providers (hospitals, ambulatories, pharmacies) for the expenses incurred in the diagnoses and treatments of a cohort of cancer patients; these cancer costs are estimated in various phases of the disease reflecting patients' patterns of care: initial, monitoring and final phase. The main methodological features are illustrated using a cohort of colon cancer cases from a Cancer Registry in Italy. This approach has been successfully implemented in Italy and it has been adapted to other European countries, such as Belgium, Norway and Poland in the framework of the Innovative Partnership for Action Against Cancer (iPAAC) Joint Action, sponsored by the European Commission. It is replicable in countries/regions where population-based cancer registry data is available and linkable at individual level with administrative data on costs of care. |
format | Online Article Text |
id | pubmed-9533128 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95331282022-10-06 Cancer cost profiles: The Epicost estimation approach Francisci, Silvia Capodaglio, Guilia Gigli, Anna Mollica, Cristina Guzzinati, Stefano Front Public Health Public Health Sustainability of cancer burden is becoming increasingly central in the policy makers' debate, and poses a challenge for the welfare systems, due to trends towards greater intensity of healthcare service use, which imply increasing costs of cancer care. Measuring and projecting the economic burden associated with cancer and identifying effective policies for minimising its impact are important issues for healthcare systems. Scope of this paper is to illustrate a novel comprehensive approach (called Epicost) to the estimation of the economic burden of cancer, based on micro-data collected from multiple data sources. It consists of a model of cost analysis to estimate the amount of reimbursement payed by the National Health Service to health service providers (hospitals, ambulatories, pharmacies) for the expenses incurred in the diagnoses and treatments of a cohort of cancer patients; these cancer costs are estimated in various phases of the disease reflecting patients' patterns of care: initial, monitoring and final phase. The main methodological features are illustrated using a cohort of colon cancer cases from a Cancer Registry in Italy. This approach has been successfully implemented in Italy and it has been adapted to other European countries, such as Belgium, Norway and Poland in the framework of the Innovative Partnership for Action Against Cancer (iPAAC) Joint Action, sponsored by the European Commission. It is replicable in countries/regions where population-based cancer registry data is available and linkable at individual level with administrative data on costs of care. Frontiers Media S.A. 2022-09-21 /pmc/articles/PMC9533128/ /pubmed/36211660 http://dx.doi.org/10.3389/fpubh.2022.974505 Text en Copyright © 2022 Francisci, Capodaglio, Gigli, Mollica and Guzzinati. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Francisci, Silvia Capodaglio, Guilia Gigli, Anna Mollica, Cristina Guzzinati, Stefano Cancer cost profiles: The Epicost estimation approach |
title | Cancer cost profiles: The Epicost estimation approach |
title_full | Cancer cost profiles: The Epicost estimation approach |
title_fullStr | Cancer cost profiles: The Epicost estimation approach |
title_full_unstemmed | Cancer cost profiles: The Epicost estimation approach |
title_short | Cancer cost profiles: The Epicost estimation approach |
title_sort | cancer cost profiles: the epicost estimation approach |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533128/ https://www.ncbi.nlm.nih.gov/pubmed/36211660 http://dx.doi.org/10.3389/fpubh.2022.974505 |
work_keys_str_mv | AT franciscisilvia cancercostprofilestheepicostestimationapproach AT capodaglioguilia cancercostprofilestheepicostestimationapproach AT giglianna cancercostprofilestheepicostestimationapproach AT mollicacristina cancercostprofilestheepicostestimationapproach AT guzzinatistefano cancercostprofilestheepicostestimationapproach |